For decades, Presidents have promised to cut prescription drug prices, but only President Donald J. Trump has delivered. Prescription drug prices have now recorded their sharpest annual drop in more than 60 years — and those lower prices now reach every Medicaid program in America. Official data confirms the largest annual decline in more than 60 years — the steepest drop since 1963 — with prices falling every month of 2026. Through Most Favored Nation pricing, 26 of the world’s largest drugmakers — covering 90% of the branded U.S. market — have agreed to bring U.S. prices in line with the lowest paid by comparable developed nations. These agreements are projected to save Americans more than $600 billion.
Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.
